British Journal of Clinical Pharmacology · 1982 · 214 citations · 14 references
PharmacyPharmacokineticsPharmacologyBioavailabilityClinical PharmacologyDrug MetabolismDrug AbsorptionDrug DispositionEnzyme InhibitionRenal Drug AbsorptionRenal Drug DistributionUrinary ExcretionAntihypertensive Drug TherapyAntihypertensive PharmacologyConcentration ProfilesPeak Serum ConcentrationTotal Drug ConcentrationsUrinary Concentration-time ProfilesUrinary Drug RecoveryUrinary Recovery Of Drugs
1 The disposition of two angiotensin converting-enzyme inhibitor drugs was studied in normal volunteers. One drug was enalapril maleate (MK-421), which requires in vivo esterolysis to yield active inhibitor (MK-422). The other was a lysine analogue of MK-422 (MK-521), which requires no bioactivation. 2 Absorption of enalapril maleate (10 mg, p.o.) was rapid, with peak serum concentrations of enalapril observed 0.5-1.5 h after administration. Based upon urinary recovery of total drug (enalapril plus MK-422), absorption was at least 61%. Bioactivation appeared to be largely post-absorptive. From the ratio of MK-422 to total drug in urine, the minimum extent of bioactivation was estimated at 0.7. 3 A similar dose of MK-521 was absorbed more slowly, reaching peak serum concentrations 6-8 h following drug administration. Minimum absorption, based upon urinary recovery, was 29%. 4 Serum concentration v time profiles for both drugs were polyphasic and exhibited prolonged terminal phases. 5 Recovery in urine and faeces of administered enalapril maleate (intact and as MK-422) was 94%. Recovery of MK-521 was 97%. These results indicate lack of significant metabolism of these agents, apart from the bioactivation of enalapril.
14
A new class of angiotensin-converting enzyme inhibitors
Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram et al. · Nature · 1980 · 706 citations
ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".
Haralambos Gavras, Bernard Waeber, Jérôme Biollaz et al. · The Lancet · 1981 · 184 citations
Disposition of captopril in normal subjects
K. J. Kripalani, Doris N. McKinstry, Sampat M. Singhvi et al. · Clinical Pharmacology & Therapeutics · 1980 · 159 citations
Dennis M. Gross, Charles S. Sweet, E H Ulm et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 150 citations